13F-HR filed by Broadfin Capital, LLC
Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 70 holding rows worth $1,028,554,000.
- Accession
- 0000919574-16-014878
- Filer
- CIK 1511901
- Filed
- 2016-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 70 entries on the cover page, a total value of $1,028,554,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,028,554,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBroadfin Healthcare Master Fund Ltd028-14254
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 550,000 | $115,211,000 | thousands by filing date | put |
| HORIZON PHARMA PLC | G4617B105 | SHS | 6,863,848 | $113,048,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 5,465,216 | $53,778,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 3,607,282 | $51,837,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 2,662,591 | $47,421,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 4,394,464 | $47,197,000 | thousands by filing date | |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 8,951,169 | $37,774,000 | thousands by filing date | |
| RAPTOR PHARMACEUTICAL CORP | 75382F106 | COM | 6,450,000 | $34,637,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 392,355 | $28,940,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 3,170,759 | $25,683,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,250,104 | $22,564,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 1,227,501 | $22,555,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 3,428,865 | $21,670,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,281,373 | $20,502,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 3,370,306 | $18,705,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 2,516,501 | $17,968,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 2,060,086 | $16,378,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 1,028,802 | $16,039,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 14,885,393 | $15,630,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 1,690,517 | $13,676,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 4,106,990 | $13,553,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 1,000,000 | $12,460,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 5,188,794 | $12,246,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 2,256,546 | $12,230,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 1,100,007 | $11,528,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 803,332 | $11,174,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 4,675,216 | $10,098,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 2,562,104 | $10,095,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 710,600 | $9,188,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 177,400 | $9,053,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 255,600 | $8,596,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 500,000 | $8,235,000 | thousands by filing date | call |
| REDHILL BIOPHARMA LTD | 757468103 | ADR | 737,156 | $8,009,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 547,810 | $7,987,000 | thousands by filing date | |
| Egalet Corporation | 28226BAB0 | Note 5.50% 4/1/20 | 10,000,000 | $7,600,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 882,312 | $7,103,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 270,400 | $7,002,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 1,557,106 | $6,991,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 1,919,721 | $6,661,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,113,293 | $6,624,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 1,656,706 | $6,594,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 324,657 | $6,370,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 4,445,527 | $6,313,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 4,010,291 | $5,975,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 8,200,000 | $5,822,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 1,134,750 | $5,628,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 1,968,631 | $5,040,000 | thousands by filing date | |
| AVIRAGEN THERAPEUTICS INC | 053761102 | COM | 3,486,711 | $4,881,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 3,094,745 | $4,735,000 | thousands by filing date | |
| NEXVET BIOPHARMA PLC | G6503X109 | ORD SHS | 1,000,000 | $4,640,000 | thousands by filing date | |
| MEDIWOUND LTD | M68830104 | ORD SHS | 530,985 | $4,189,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 693,863 | $3,788,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 1,154,674 | $3,568,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HLDGS IN | 71426VAK4 | DBCV 4.250 4/0 | 15,500,000 | $3,565,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 2,900,000 | $3,538,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 1,477,273 | $3,206,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 93,380 | $3,150,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 200,000 | $3,118,000 | thousands by filing date | call |
| TREVENA INC | 89532E109 | COM | 492,000 | $3,100,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 652,505 | $1,886,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 166,875 | $1,720,000 | thousands by filing date | |
| DEXTERA SURGICAL INC COM | 252366109 | CS | 862,499 | $1,552,000 | thousands by filing date | |
| WINDTREE THERAPEUTICS INC | 97382D105 | COM | 777,797 | $1,501,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 810,852 | $1,492,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 2,025,268 | $1,296,000 | thousands by filing date | |
| RITTER PHARMACEUTICALS INC | 767836109 | COM | 768,418 | $1,176,000 | thousands by filing date | |
| RXI PHARMACEUTICALS CORP NEW | 74979C501 | COM | 488,425 | $1,172,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 433,911 | $863,000 | thousands by filing date | |
| STRATA SKIN SCIENCES INC | 86272A107 | COM | 961,422 | $586,000 | thousands by filing date | |
| DIPEXIUM PHARMACEUTICALS INC | 25456J104 | COM | 44,774 | $444,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-16-014878 | this filing | 2016-08-15 | acceptance time not in the bulk data set |